Roche Diagnostics Belgium (A): Changing a winning formula
The Roche Diagnostics Belgium (RDB) case study consists of two parts: Part (A): “Changing a Winning Formula?” and Part (B): Cultural and Digital transformation. The cases focus on the transformation which Anna-Maria Heuchel-Reinig initiated to turn the company into a more successful business. RDB had a strong track-record within Roche for high-performance and good market share. Anna had an equally solid reputation, having managed different businesses and country organizations within Roche over a 20-year career. The two-part case study covers the period from April 2017 until October 2019 and recounts how Anna made sense of the situation she inherited when she became the General Manager of the Belgian organisation and the actions she took to initiate a journey focused on customer centricity, cultural change and digital business transformation. Case A covers Anna’s first 100 days as General Manager from April 2017 – August 2017. She was told that RDB was a high performing, customer-focused organization, yet she encountered a company living on past successes with weakening customer focus. The case outlines the company context, Anna’s early encounters with the Belgian organization, her developing concerns and the gap between RDB’s narrative of success and her own assessment of the company.
- How do leaders make sense of the situations they have been hired to lead when their sense-making is counter to the prevailing narrative?
- How do leaders navigate their first 90 days in a new role?
Roche Holding, Healthcare, Health and Medical Services
April 2017 – October 2019
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
The case study explores the second phase of ABB's 2018 to 2024 transformation journey to restore confidence in the underperforming conglomerate through a simplification of its structure and a focus on accelerating decision making. Under interim CE...
This case series explores Sandoz's spin off from Novartis, which was finalized on 4 October 2023. Case B looks at Sandoz once it has become independent. The hard work of figuring out the best way to spin off is done, a new strategy created, and so...
The Sandoz leadership team faced an important decision as it broke away from Novartis and became a public company. Should Sandoz retain the global geographical coverage it had had in its many years as part of Novartis? Or should it focus on fewer ...
This case series explores Sandoz's spin off from Novartis, which was finalized on 4 October 2023. Case A follows Richard Saynor's (CEO, Sandoz) ruminations as he builds the company strategy in preparation for the board's approval of Sandoz as a st...
The case study explores the first phase of ABB's 2018 to 2024 transformation journey as it tackled longstanding challenges: financial underperformance, declining market confidence and inefficiencies in its complex matrix structure. To streamline o...
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-2670 ©2025
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-2669 ©2025
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications